trial

An Integrated Program for the Treatment of First Episode of Psychosis

NCTId NCT01321177
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 404 (actual)
Sponsored by Northwell Health, Early Treatment Program at Lenox Hill
Primary completion 2014-07
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
404 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2010-07
Primary completion
2014-07
Eligibility
ALL · 15 Years · 40 Years

Interventions & indications

Drugs
Integrated TreatmentCommunity Care

Sponsors

Northwell Health, Early Treatment Program at Lenox HillLead Sponsor
State University of New York - Downstate Medical CenterCollaborator
University of North Carolina, Chapel HillCollaborator
University of California Riverside at C.I. Trials, Inc.-Inland EmpireCollaborator
Dartmouth-Hitchcock Medical CenterCollaborator
Research Foundation for Mental Hygiene, Inc.Collaborator
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
John M Kane, MDPrincipal Investigator

Sites

33 total
San Fernando, United StatesSanta Clarita, United StatesDenver, United StatesWillimantic, United StatesFort Lauderdale, United StatesPanama City, United StatesAtlanta, United StatesAustell, United StatesFort Wayne, United StatesLawrenceburg, United StatesDes Moines, United StatesHouma, United States

Facts & assertions

4 sourced
Enrollment
404
Phase
NA
Primary Completion Date
2014-07
Status
COMPLETED
relationships
The graph out of here
drug
Integrated Treatment
drug
Community Care
drug
lead_sponsor
Northwell Health, Early Treatment Program at Lenox Hill
company
collaborator
State University of New York - Downstate Medical Center
company
University of North Carolina, Chapel Hill
company
indication
Schizophreniform Disorder
indication
Schizoaffective Disorder
indication
Psychotic Disorder NOS
indication
investigator
John M Kane, MD
person